Published in MBio on October 06, 2015
Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions. MBio (2015) 1.00
Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen Streptococcus pyogenes. MBio (2016) 0.92
Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains? Curr Opin Infect Dis (2016) 0.78
Intergenic Variable-Number Tandem-Repeat Polymorphism Upstream of rocA Alters Toxin Production and Enhances Virulence in Streptococcus pyogenes. Infect Immun (2016) 0.77
Contemporary Pharyngeal and Invasive emm1 and Invasive emm12 Group A Streptococcus Isolates Exhibit Similar In Vivo Selection for CovRS Mutants in Mice. PLoS One (2016) 0.77
Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014. J Infect Dis (2016) 0.77
Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections. Eur J Clin Microbiol Infect Dis (2017) 0.76
Contribution of Secreted NADase and Streptolysin O to the Pathogenesis of Epidemic Serotype M1 Streptococcus pyogenes Infections. Am J Pathol (2016) 0.76
Evolutionary Constraints Shaping Streptococcus pyogenes-Host Interactions. Trends Microbiol (2017) 0.75
Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease. Open Forum Infect Dis (2017) 0.75
Opacification Domain of Serum Opacity Factor Inhibits Beta-Hemolysis and Contributes to Virulence of Streptococcus pyogenes. mSphere (2017) 0.75
Application of Whole-Genome Sequencing to an Unusual Outbreak of Invasive Group A Streptococcal Disease. Open Forum Infect Dis (2016) 0.75
Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015. MBio (2017) 0.75
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36
Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis (2009) 3.51
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2009) 2.80
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem (1999) 1.90
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis (2007) 1.66
RocA truncation underpins hyper-encapsulation, carriage longevity and transmissibility of serotype M18 group A streptococci. PLoS Pathog (2013) 1.58
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom. MBio (2015) 1.54
Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A (2010) 1.47
The group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcript. Mol Microbiol (2010) 1.37
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis (2011) 1.32
A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest (2015) 1.29
Invasive group A streptococcal infections in adults, France (2006-2010). Clin Microbiol Infect (2011) 1.27
Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis. MBio (2012) 1.27
A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase. PLoS Pathog (2005) 1.20
Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing. PLoS Pathog (2013) 1.16
Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol (2010) 1.14
A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog (2010) 1.10
Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol (2012) 1.08
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis (2011) 1.04
Genetic and biochemical properties of streptococcal NAD-glycohydrolase inhibitor. J Biol Chem (2005) 1.03
Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages. MBio (2014) 1.02
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol (2011) 1.02
Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition. Int J Med Microbiol (2013) 1.02
Molecular characterization of NADase-streptolysin O operon of hemolytic streptococci. Biochim Biophys Acta (2004) 0.98
Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012. Epidemiol Infect (2015) 0.93
Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis (2011) 0.89
Streptococcus pyogenes emm-types in northern Spain; population dynamics over a 7-year period. J Infect (2013) 0.87
Molecular characterization of Streptococcus pyogenes group A isolates from a tertiary hospital in Lebanon. J Med Microbiol (2014) 0.86
Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements. Infect Immun (2014) 0.85
Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. PLoS One (2013) 0.81